220 related articles for article (PubMed ID: 38041930)
1. Effects of the G-quadruplex-binding drugs quarfloxin and CX-5461 on the malaria parasite Plasmodium falciparum.
Craven HM; Nettesheim G; Cicuta P; Blagborough AM; Merrick CJ
Int J Parasitol Drugs Drug Resist; 2023 Dec; 23():106-119. PubMed ID: 38041930
[TBL] [Abstract][Full Text] [Related]
2. G-Quadruplex DNA Motifs in the Malaria Parasite Plasmodium falciparum and Their Potential as Novel Antimalarial Drug Targets.
Harris LM; Monsell KR; Noulin F; Famodimu MT; Smargiasso N; Damblon C; Horrocks P; Merrick CJ
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311059
[TBL] [Abstract][Full Text] [Related]
3. Antimalarials Targeting the Malaria Parasite Cation ATPase
Zagórska A; Jaromin A
Curr Top Med Chem; 2023; 23(3):214-226. PubMed ID: 36411573
[TBL] [Abstract][Full Text] [Related]
4. Local emergence in Amazonia of
Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
Elife; 2020 May; 9():. PubMed ID: 32394893
[TBL] [Abstract][Full Text] [Related]
5. Cation ATPase (ATP4) Orthologue Replacement in the Malaria Parasite Plasmodium knowlesi Reveals Species-Specific Responses to ATP4-Targeting Drugs.
Mohring F; van Schalkwyk DA; Henrici RC; Blasco B; Leroy D; Sutherland CJ; Moon RW
mBio; 2022 Oct; 13(5):e0117822. PubMed ID: 36190127
[TBL] [Abstract][Full Text] [Related]
6. Targeting malaria parasites with novel derivatives of azithromycin.
Burns AL; Sleebs BE; Gancheva M; McLean KT; Siddiqui G; Venter H; Beeson JG; O'Handley R; Creek DJ; Ma S; Frölich S; Goodman CD; McFadden GI; Wilson DW
Front Cell Infect Microbiol; 2022; 12():1063407. PubMed ID: 36530422
[TBL] [Abstract][Full Text] [Related]
7. The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to
Murithi JM; Pascal C; Bath J; Boulenc X; Gnädig NF; Pasaje CFA; Rubiano K; Yeo T; Mok S; Klieber S; Desert P; Jiménez-Díaz MB; Marfurt J; Rouillier M; Cherkaoui-Rbati MH; Gobeau N; Wittlin S; Uhlemann AC; Price RN; Wirjanata G; Noviyanti R; Tumwebaze P; Cooper RA; Rosenthal PJ; Sanz LM; Gamo FJ; Joseph J; Singh S; Bashyam S; Augereau JM; Giraud E; Bozec T; Vermat T; Tuffal G; Guillon JM; Menegotto J; Sallé L; Louit G; Cabanis MJ; Nicolas MF; Doubovetzky M; Merino R; Bessila N; Angulo-Barturen I; Baud D; Bebrevska L; Escudié F; Niles JC; Blasco B; Campbell S; Courtemanche G; Fraisse L; Pellet A; Fidock DA; Leroy D
Sci Transl Med; 2021 Jul; 13(603):. PubMed ID: 34290058
[TBL] [Abstract][Full Text] [Related]
8. The Medicines for Malaria Venture Malaria Box contains inhibitors of protein secretion in Plasmodium falciparum blood stage parasites.
Looker O; Dans MG; Bullen HE; Sleebs BE; Crabb BS; Gilson PR
Traffic; 2022 Sep; 23(9):442-461. PubMed ID: 36040075
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium berghei K13 Mutations Mediate
Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. A randomized feasibility trial comparing four antimalarial drug regimens to induce
Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
Elife; 2018 Feb; 7():. PubMed ID: 29482720
[TBL] [Abstract][Full Text] [Related]
12. Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity.
Vanaerschot M; Lucantoni L; Li T; Combrinck JM; Ruecker A; Kumar TRS; Rubiano K; Ferreira PE; Siciliano G; Gulati S; Henrich PP; Ng CL; Murithi JM; Corey VC; Duffy S; Lieberman OJ; Veiga MI; Sinden RE; Alano P; Delves MJ; Lee Sim K; Winzeler EA; Egan TJ; Hoffman SL; Avery VM; Fidock DA
Nat Microbiol; 2017 Oct; 2(10):1403-1414. PubMed ID: 28808258
[TBL] [Abstract][Full Text] [Related]
13. In silico multiple-targets identification for heme detoxification in the human malaria parasite Plasmodium falciparum.
Phaiphinit S; Pattaradilokrat S; Lursinsap C; Plaimas K
Infect Genet Evol; 2016 Jan; 37():237-44. PubMed ID: 26626103
[TBL] [Abstract][Full Text] [Related]
14. Screening the Pathogen Box for Inhibition of Plasmodium falciparum Sporozoite Motility Reveals a Critical Role for Kinases in Transmission Stages.
Kanatani S; Elahi R; Kanchanabhogin S; Vartak N; Tripathi AK; Prigge ST; Sinnis P
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0041822. PubMed ID: 35943271
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages.
Ke H; Ganesan SM; Dass S; Morrisey JM; Pou S; Nilsen A; Riscoe MK; Mather MW; Vaidya AB
PLoS One; 2019; 14(4):e0214023. PubMed ID: 30964863
[TBL] [Abstract][Full Text] [Related]
16. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
[TBL] [Abstract][Full Text] [Related]
17. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.
Biagini GA; Fisher N; Shone AE; Mubaraki MA; Srivastava A; Hill A; Antoine T; Warman AJ; Davies J; Pidathala C; Amewu RK; Leung SC; Sharma R; Gibbons P; Hong DW; Pacorel B; Lawrenson AS; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Stocks PA; Nixon GL; Chadwick J; Hemingway J; Delves MJ; Sinden RE; Zeeman AM; Kocken CH; Berry NG; O'Neill PM; Ward SA
Proc Natl Acad Sci U S A; 2012 May; 109(21):8298-303. PubMed ID: 22566611
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation.
Sindhe KMV; Wu W; Legac J; Zhang YK; Easom EE; Cooper RA; Plattner JJ; Freund YR; DeRisi JL; Rosenthal PJ
mBio; 2020 Jan; 11(1):. PubMed ID: 31992618
[TBL] [Abstract][Full Text] [Related]
19. Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4.
Ashton TD; Dans MG; Favuzza P; Ngo A; Lehane AM; Zhang X; Qiu D; Chandra Maity B; De N; Schindler KA; Yeo T; Park H; Uhlemann AC; Churchyard A; Baum J; Fidock DA; Jarman KE; Lowes KN; Baud D; Brand S; Jackson PF; Cowman AF; Sleebs BE
J Med Chem; 2023 Mar; 66(5):3540-3565. PubMed ID: 36812492
[TBL] [Abstract][Full Text] [Related]
20. Dramatic Consequences of Reducing Erythrocyte Membrane Cholesterol on Plasmodium falciparum.
Ahiya AI; Bhatnagar S; Morrisey JM; Beck JR; Vaidya AB
Microbiol Spectr; 2022 Feb; 10(1):e0015822. PubMed ID: 35196803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
